Lipolytic and antilipolytic responses of the Siberian hamster (Phodopus sungorus sungorus) white adipocytes after weight loss induced by short photoperiod exposure.
Short day photoperiod promotes thermogenesis and extensive weight loss in Siberian hamsters (Phodopus sungorus sungorus). To determine whether a change in hormone-sensitive lipolysis occurs after short-photoperiod exposure, some lipolytic responses were measured on white adipocytes isolated from animals exposed in warm conditions to short or Long daylight photoperiod. The body mass of male Siberian hamsters exposed during 11 weeks to short days (SD; light: dark, 6:18 hr) reached only 50% of those kept in long days (LD; 16: 8 hr). In SD-hamsters, adipose depot mass also represented approximately 50% of the LD group. A lower DNA content was observed in intra-abdominal fat pads of SD-hamsters. Lipolytic responses to noradrenaline, adrenaline, isoproterenol and ACTH were unchanged. However, sensitivity to the beta-3 adrenergic agonist, BRL 37344, was moderately increased. The major component of the adrenergic control of lipolysis was mediated by beta-3 adrenoceptors in both LD- and SD-Siberian hamsters. The limited antilipolytic effect of alpha-2 adrenergic agonists, PYY or insulin was rather surprising in Siberian hamsters since these inhibitory systems are efficient in hibernants and other photoperiod-sensitive rodents. Our results show that, after short photoperiod exposure, white adipose tissue mass and DNA content are reduced, especially in the epididymal fat pad, with only minor changes in the adipocyte sensitivity to lipolytic hormones.
UPS UPRESA 5018, CHU Rangueil, Toulouse, France.
C
C
Atgié
S
S
Le Gouic
L
L
Marti
N
N
Hanoun
L
L
Casteilla
L
L
Pénicaud
L
L
Ambid
C
C
Carpéné
D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D006224:Cricetinae; D004247:DNA / Q000032:analysis; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000502:physiology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D019894:Peptide YY / Q000494:pharmacology; D017111:Phodopus; D017440:Photoperiod; D011412:Propanolamines / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D015430:Weight Gain / Q000502:physiology; D015431:Weight Loss / Q000502:physiology*
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D011412:Propanolamines; D013566:Sympathomimetics; D019894:Peptide YY; C057368:BRL 37344; D000324:Adrenocorticotropic Hormone; D004247:DNA; D007545:Isoproterenol; C033394:CGP 12177; D009638:Norepinephrine; D004837:Epinephrine